ICYMI: New CBO Report highlights biopharmaceutical leadership in the development of new treatments and cures

America ’s biopharmaceutical companies are at the heart of a research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing development of new, life-saving and life-improving medicines, including those forCOVID-19, would not be possible without the robust investment, scientific expertise and manufacturing capabilities from biopharmaceutical research companies.
Source: The Catalyst - Category: Pharmaceuticals Tags: R & D Focus COVID-19 Source Type: news